What tucatinib means for oncologists and their patients: an interview with Erika Hamilton

Written by Erika Hamilton

cancer cell image

Please introduce yourself and tell us about your career to date. I’m Erika Hamilton and I lead Breast Cancer Research at Sarah Cannon Research Institute at Tennessee Oncology in Nashville (TN, USA). I am also a partner within Tennessee Oncology, PLLC.  I joined Sarah Cannon in 2013 and focus on breast cancer and gynecologic cancer. I care for patients receiving standard therapies and am the primary investigator on many of our late Phase breast cancer studies and in our Phase I Drug Development Unit. I am passionate about improving the care for people facing breast cancer and bringing new and...

To view this content, please register now for access

It's completely free